期刊文献+

解毒消痈冲剂对胃溃疡活动期毒热病因要素的干预效果 被引量:3

Clinical effects of Jiedu Xiaoyong granules in treatment of active gastric ulcer
在线阅读 下载PDF
导出
摘要 目的:探讨针对胃溃疡(gastric ulcer,GU)活动期毒热病因要素的中药干预效果.方法:按照随机数字表法将江西中医药大学附属医院收治的98例GU患者均分为实验组和对照组,实验组患者给予解毒消痈冲剂治疗,对照组患者给予安胃疡胶囊治疗,比较两组患者治疗后中医症状评分改善情况、黄苔或黄腻苔、白腻苔消失率、幽门螺杆菌(Helicobacter pylori,H.pylori)根除率、临床疗效以及治疗期间不良反应发生情况.结果:两组患者治疗后各项中医症状评分均显著下降,与治疗前比较,(1.31±1.22 vs 4.11±1.42)、(0.91±1.19 vs 3.02±1.11)、(0.92±1.29 vs 3.13±1.06)、(0.50±0.71 vs 1.98±0.91)、(0.42±0.39 vs 1.84±0.69)、(0.62±0.60 vs 1.61±0.80),(2.33±1.30 vs 4.12±1.40)、(1.52±1.38 vs 2.98±1.10)、(1.60±0.88 vs 3.12±1.08)、(1.01±0.69 vs 2.00±0.88)、(0.79±0.80 vs 1.82±0.80)、(0.91±0.79 vs 1.62±0.79),差异具有统计学意义(P<0.05);实验组患者治疗后各项中医症状评分下降幅度均显著高于对照组,(1.31±1.22vs 2.33±1.30)、(0.91±1.19 vs 1.52±1.38)、(0.92±1.29 vs 1.60±0.88)、(0.50±0.71 vs1.01±0.69)、(0.42±0.39 vs 0.79±0.80)、(0.62±0.60 vs 0.91±0.79),差异具有统计学意义(P<0.05);实验组患者治疗后黄苔或黄腻苔、白腻苔消失率和H.pylori根除率均显著高于对照组,(77.55%vs 42.86%)、(65.31%vs38.78%),差异具有统计学意义(P<0.05);实验组患者痊愈率和总有效率均显著高于对照组,(67.35%vs 34.69%)、(97.96%vs 75.51%),差异具有统计学意义(P<0.05).结论:解毒消痈冲剂能够有效改善GU患者中医症状和舌像,H.pylori根除率高,临床疗效显著,无不良反应,可作为治疗活动期GU的优选药物. AIM: To assess the clinical effects of Jiedu Xiaoy- ong granules in the treatment of active gastric ulcer (GU). METHODS: Ninety-eight patients with active GU were randomly divided into either an ex- periment group or a control group. The experi- ment group was treated with Jiedu Xiaoyong granules, and the control group was treated with Anweiyang capsules. The traditional Chinese medicine symptom scores, the disappearance rates of yellow tongue coating and white greasy moss, the eradication rate of Helicobacter pylori (H. pylori), clinical effect and adverse reactions were compared between the two groups. RESULTS: The scores of traditional Chinese med- icine symptoms in both groups were significantly lower after treatment than before treatment (1.31± 1.22 vs 4.11 ± 1.42, 0.91 ± 1.19 vs 3.02 ± 1.11, 0.92 ± 1.29 vs 3.13 ± 1.06, 0.50 ± 0.71 vs 1.98 ± 0.91, 0.42 ± 0.39 vs 1.84 ± 0.69, 0.62 ± 0.60 vs 1.61 ± 0.80, 2.33 ± 1.30 vs 4.12 ± 1.40, 1.52 ± 1.38 vs 2.98 ± 1.10, 1.60 ± 0.88 vs 3.12 ± 1.08, 1.01 ± 0.69 vs 2.00 ± 0.88, 0.79 ± 0.80 vs 1.82 ± 0.80, 0.91 ± 0.79 vs 1.62 ± 0.79; P 〈 0.05); the decreases in the scores of traditional Chi- nese medicine symptoms in the experiment group were significantly higher than those in the control group (1.31 ± 1.22 vs 2.33 ± 1.30, 0.91 ± 1.19 vs 1.52 ± 1.38, 0.92 ± 1.29 vs 1.60 ± 0.88, 0.50 ± 0.71 vs 1.01 ± 0.69, 0.42 ± 0.39 vs 0.79 ± 0.80, 0.62 ± 0.60 vs 0.91 ± 0.79; P 〈 0.05). The disappearance rates of yellow tongue coating and white greasy moss as well as the eradication rate of H. pylori in the experiment group were significantly higher than those in the control group (77.55% vs 42.86%, 65.31% vs 38.78%; P 〈 0.05). The recovery rate and total effective rate in the experiment group were also significantly higher than those in the control group (67.35% vs 34.69%, 97.96% vs 75.51%; P 〈 0.05). CONGLUSION: Jiedu Xiaoyong granules can improve Chinese medicine symptoms and tongue image in patients with active GU, and is associated with a high eradication rate of H. pylori, distinct clinical effects, and very few ad- verse reactions.
出处 《世界华人消化杂志》 CAS 北大核心 2014年第26期3968-3971,共4页 World Chinese Journal of Digestology
关键词 胃溃疡 毒热 解毒消痈冲剂 安胃疡胶囊 干预效果 Gastric ulcer Heat toxicity Jiedu Xi-aoyong granules Anweiyang capsules Interventioneffect
  • 相关文献

参考文献15

  • 1尹江燕,陈道荣.消化性溃疡药物治疗的进展[J].医学综述,2013,19(11):2000-2002. 被引量:75
  • 2Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EL Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenter- ology 2012; 142: 46-54.e42; quiz e30 [PMID: 22001864 DOI: 10.1053/j.gastro.2011.10.001].
  • 3陈灏珠,林果为,王吉耀.实用内科学.第14版.北京:人民卫生出版社,2013:2600-2610.
  • 4刘林,王垂杰,郑洪新,周学文,李慧臻,时昭红,董爱民,于庆功,黄煜,姜巍,白光,李玉锋,汤立东,李岩,王辉,马乾章.“以效证因”消痈溃得康治疗胃溃疡胃毒热证的随机双盲对照临床试验[J].世界科学技术-中医药现代化,2012,14(2):1399-1404. 被引量:22
  • 5焦洁,张心海.胃溃疡的中医药治疗研究进展[J].四川中医,2013,31(10):156-158. 被引量:3
  • 6Ahrens D, Chenot JF, Behrens (3, (3rimmsmann l, Kochen MM. Appropriateness of treatment recom- mendations for PPI in hospital discharge letters. Eur JClin Pharmacol 2010; 66:1265-1271 [PMID: 20694459 DOI: 10.1007/s00228-010-0871-9].
  • 7Garrow D, Delegge MH. Risk factors for gastroin- testinal ulcer disease in the US population. Dig Dis Sc/2010; 55:66-72 [PMID: 19160043 DOI: 10.1007/ s10620-008-0708-x].
  • 8Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China. J Dig Dis 2010; 11:76-82 [PMID: 20402832 DOI: 10.1111/ j.1751-2980.2010.00421.x].
  • 9汤立东,王垂杰,周学文,李慧臻,时昭红,董爱民,于庆功,姜巍,白光,李玉锋,马乾章,李岩,黄煜,刘林,王辉.活动性胃溃疡及幽门螺杆菌与中医毒热证的关联研究[J].辽宁中医杂志,2011,38(11):2218-2221. 被引量:13
  • 10谢一嫏,黄其春.质子泵抑制剂防治化疗引起胃肠道黏膜损伤的研究进展[J].世界华人消化杂志,2014,22(5):642-647. 被引量:9

二级参考文献128

共引文献156

同被引文献78

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部